BR112014027919A2 - compostos complexos de germânio, métodos de produção dos mesmos e medicamentos. - Google Patents

compostos complexos de germânio, métodos de produção dos mesmos e medicamentos.

Info

Publication number
BR112014027919A2
BR112014027919A2 BR112014027919A BR112014027919A BR112014027919A2 BR 112014027919 A2 BR112014027919 A2 BR 112014027919A2 BR 112014027919 A BR112014027919 A BR 112014027919A BR 112014027919 A BR112014027919 A BR 112014027919A BR 112014027919 A2 BR112014027919 A2 BR 112014027919A2
Authority
BR
Brazil
Prior art keywords
medicines
production methods
germanium compounds
complex
complex germanium
Prior art date
Application number
BR112014027919A
Other languages
English (en)
Other versions
BR112014027919B1 (pt
Inventor
Igor Valerievich Ambrosov
Alexandr Dmitrievich Isaev
Tamaz Omarovich Manasherov
Svetlana Konstantinovna Matelo
Original Assignee
Obschestvo S Ogranichennoi Otvetstvennostyu Wds Farma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Obschestvo S Ogranichennoi Otvetstvennostyu Wds Farma filed Critical Obschestvo S Ogranichennoi Otvetstvennostyu Wds Farma
Publication of BR112014027919A2 publication Critical patent/BR112014027919A2/pt
Publication of BR112014027919B1 publication Critical patent/BR112014027919B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/30Germanium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542Carboxylic acids, e.g. a fatty acid or an amino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/547Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
BR112014027919A 2012-05-16 2012-11-01 compostos complexos de germânio, métodos de produção dos mesmos e medicamentos. BR112014027919B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2012120329/04A RU2487878C1 (ru) 2012-05-16 2012-05-16 Комплексные соединения германия с производными азотистых оснований пуринового ряда, способы их получения и содержащие их лекарственные средства
PCT/RU2012/000897 WO2013172732A1 (ru) 2012-05-16 2012-11-01 Комплексные соединения германия, способы их получения и лекарственные средства

Publications (2)

Publication Number Publication Date
BR112014027919A2 true BR112014027919A2 (pt) 2017-06-27
BR112014027919B1 BR112014027919B1 (pt) 2020-02-04

Family

ID=48791166

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014027919A BR112014027919B1 (pt) 2012-05-16 2012-11-01 compostos complexos de germânio, métodos de produção dos mesmos e medicamentos.

Country Status (16)

Country Link
US (1) US9745337B2 (pt)
EP (1) EP2851368B1 (pt)
JP (1) JP5993088B2 (pt)
KR (1) KR101717280B1 (pt)
CN (1) CN104302651B (pt)
AU (1) AU2012380376B2 (pt)
BR (1) BR112014027919B1 (pt)
CA (1) CA2873390C (pt)
DK (1) DK2851368T3 (pt)
ES (1) ES2710915T3 (pt)
IN (1) IN2014DN09234A (pt)
PL (1) PL2851368T3 (pt)
PT (1) PT2851368T (pt)
RU (1) RU2487878C1 (pt)
TR (1) TR201901561T4 (pt)
WO (1) WO2013172732A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2626954C2 (ru) * 2015-11-11 2017-08-02 Общество С Ограниченной Ответственностью "Вдс Фарма" Комплексные соединения германия с аминокислотами и липоевой кислотой
RU2752934C1 (ru) * 2020-10-16 2021-08-11 Александр Дмитриевич Исаев Комплексные соединения германия с ациклическими полиолами и способ их получения
CN114133398B (zh) * 2021-12-31 2022-11-22 中南民族大学 氨基酸取代的阿昔洛韦类三环核苷衍生物及其合成方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3616208A (en) * 1967-09-29 1971-10-26 Parke Davis & Co Fermentation process for 9-(beta-d-arabinofuranosyl)adenine
JPS4924213B1 (pt) * 1969-04-02 1974-06-21
JPS4924213A (pt) 1972-06-19 1974-03-04
DE3212817A1 (de) * 1982-04-06 1983-10-13 Sanum-Kehlbeck GmbH & Co KG, 2812 Hoya Pharmazeutisch wirksame organische germaniumverbindungen und verfahren zu deren herstellung
EP0477871A3 (en) 1990-09-28 1992-12-02 Nippon Kayaku Kabushiki Kaisha Antiviral composition, containing guanine derivatives
CN1154359A (zh) 1996-01-12 1997-07-16 常达正 氨基酸锗的制备方法及其应用
NZ334423A (en) * 1996-09-05 2000-07-28 Primamedic Ltd 1:2 complex of germanium and 1,3-dicarboxylic acid
RU2104032C1 (ru) * 1997-03-11 1998-02-10 Общество с ограниченной ответственностью "Снежный барс" Способ усиления лечебного эффекта лекарственных средств
RU2233286C2 (ru) * 1998-08-17 2004-07-27 Евгений Владимирович Соловьев Биохимические комплексы германия с высокой терапевтической активностью и широким спектром использования
DE50000678D1 (de) 1999-02-22 2002-11-28 Gernot Treusch Therapeutisch wirksames stoffgemisch enthaltend s-acetylglutathion und aciclovir
RU2240792C2 (ru) 2002-07-30 2004-11-27 Государственное учреждение Научно-исследовательский институт вирусологии им. Д.И. Ивановского РАМН Комбинации на основе нетропсина или его бис-производного, обладающие антигерпетической активностью
RU2233280C1 (ru) 2003-03-25 2004-07-27 Научно-исследовательский институт физической и органической химии Ростовского государственного университета СОЛИ-10-ω-АРИЛОКСИАЛКИЛ-2,3,4,10-ТЕТРАГИДРОПИРИМИДО[1,2-A]БЕНЗИМИДАЗОЛА, ОБЛАДАЮЩИЕ МЕСТНОАНЕСТЕЗИРУЮЩИМ ДЕЙСТВИЕМ
DE10343365A1 (de) 2003-09-17 2005-04-14 Biosphings Ag Pharmazeutische Formulierungen von Xanthogenaten und Hemmstoffen der viralen Nukleinsäurereplikation
RU2476436C1 (ru) * 2012-01-25 2013-02-27 Общество С Ограниченной Ответственностью "Вдс Фарма" Комплексные соединения германия с аминокислотами и карбоновыми кислотами

Also Published As

Publication number Publication date
US20150126726A1 (en) 2015-05-07
CA2873390C (en) 2017-10-24
DK2851368T3 (en) 2019-02-25
JP2015518823A (ja) 2015-07-06
EP2851368B1 (en) 2019-01-02
KR101717280B1 (ko) 2017-03-17
WO2013172732A1 (ru) 2013-11-21
PT2851368T (pt) 2019-02-11
CA2873390A1 (en) 2013-11-21
IN2014DN09234A (pt) 2015-07-10
ES2710915T3 (es) 2019-04-29
JP5993088B2 (ja) 2016-09-14
EP2851368A4 (en) 2016-02-10
BR112014027919B1 (pt) 2020-02-04
US9745337B2 (en) 2017-08-29
PL2851368T3 (pl) 2019-06-28
AU2012380376A1 (en) 2014-12-04
RU2487878C1 (ru) 2013-07-20
CN104302651A (zh) 2015-01-21
AU2012380376B2 (en) 2015-10-01
CN104302651B (zh) 2017-04-12
EP2851368A1 (en) 2015-03-25
KR20150011386A (ko) 2015-01-30
TR201901561T4 (tr) 2019-02-21

Similar Documents

Publication Publication Date Title
BR112014032116A2 (pt) método.
BR112015011903A2 (pt) dispositivo de rastreamento.
DK2822575T3 (da) Manipulerede, muterede antistof-interferon-fusionsmolekyler
BR302012004030S1 (pt) Configuração aplicada em jaqueta.
BR112014026818A2 (pt) método, produto e sistema.
BR112014032872A2 (pt) processamento de biomassa.
BR112015003259A2 (pt) composto, composição farmacêutica, e, composição de vacina.
BR112014026864A2 (pt) sistema, e método
BR112014032838A2 (pt) método , e aparelho.
BR112015013892A2 (pt) simulador.
BR112015013155A2 (pt) método, e sistema
CL2014003283A1 (es) Formulación farmacéutica.
BR112014024216A2 (pt) processo, composições, sistema e produto
BR112015010797A2 (pt) compostos aniônicos substituídos, e, composição farmacêutica
FR2986872B1 (fr) .
BR112015004419A2 (pt) artigo e método.
ITTO20130048A1 (it) Motociclo.
BR112014032501A2 (pt) composto, e, composição farmacêutica.
BR112014027919A2 (pt) compostos complexos de germânio, métodos de produção dos mesmos e medicamentos.
BR112014027645A2 (pt) 5-halogenopirazol bifenilcarboxamidas.
FR3000112B1 (fr) Structure de securite.
FR2987595B1 (fr) Trottinette.
BR112015003217A2 (pt) novos derivados de piridina.
ES1077797Y (es) Dispositivo de seguridad.
BR112014027642A2 (pt) 5-halogenopirazole-benzofuranil-carboxamidas.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/11/2012, OBSERVADAS AS CONDICOES LEGAIS.